We further investigate the impact of PRC2 and H3K27 methylation on regulating the binding of the MLL–MEN1 complex and determine the therapeutic implication of this crosstalk in the context of diffuse large B-cell lymphomas (DLBCLs) harboring gain-of-function EZH2 mutations. This evidence concerns the gene KMT2A and diffuse large B-cell lymphoma.